I agree that this site is using cookies. You can find further informations here.
X
Waksal, Julian A.
16  results:
Search for persons X
?
1

Management of isocitrate dehydrogenase 1/2 mutated acute my..:

Fruchtman, Harry ; Avigan, Zachary M. ; Waksal, Julian A...
Leukemia.  38 (2024)  5 - p. 927-935 , 2024
Link: https://doi.org/10.1038/..
 
?
2

A novel application of XPO1 inhibition for the treatment of..:

Metzger, Megan ; Avigan, Zachary M. ; Vachhani, Pankit..
Blood Neoplasia.  1 (2024)  2 - p. 100010 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Telomerase-targeted therapies in myeloid malignancies:

Waksal, Julian A. ; Bruedigam, Claudia ; Komrokji, Rami S...
Blood Advances.  7 (2023)  16 - p. 4302-4314 , 2023
Link: https://doi.org/10.1182/..
 
?
4

Safety and efficacy of CPX-351 in younger patients (<60 yea..:

Przespolewski, Amanda ; Goldberg, Aaron D. ; Talati, Chetasi...
Blood.  141 (2023)  12 - p. 1489-1493 , 2023
Link: https://doi.org/10.1182/..
 
?
5

Treating accelerated and blast phase myeloproliferative neo..:

Ajufo, Helen O. ; Waksal, Julian A. ; Mascarenhas, John O..
Therapeutic Advances in Hematology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
6

Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors:

Waksal, Julian A. ; Mascarenhas, John
Current Hematologic Malignancy Reports.  17 (2022)  5 - p. 140-154 , 2022
Link: https://doi.org/10.1007/..
 
?
7

Contemporary and future strategies in polycythemia vera:

Waksal, Julian A. ; Tremblay, Douglas A.
Best Practice & Research Clinical Haematology.  35 (2022)  2 - p. 101370 , 2022
Link: https://doi.org/10.1016/..
 
?
8

Clinical Utility of Fedratinib in Myelofibrosis:

Waksal, Julian A ; Tremblay, Douglas ; Mascarenhas, John
OncoTargets and Therapy.  14 (2021)  - p. 4509-4521 , 2021
Link: https://doi.org/10.2147/..
 
?
9

Controlled branching of polyglycidol and formation of prote..:

Spears, Benjamin R. ; Waksal, Julian ; McQuade, Caitlin..
Chemical Communications.  49 (2013)  24 - p. 2394 , 2013
Link: https://doi.org/10.1039/..
 
?
10

Plasmodium falciparum-Induced Autoimmune Hemolytic Anemia i..:

Rupani, Karishma Vijay ; Waksal, Julian ; Cytryn, Lawrence.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111286/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Telomerase-targeted therapies in myeloid malignancies:

Waksal, Julian A ; Bruedigam, Claudia ; Komrokji, Rami S..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424149/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Treating accelerated and blast phase myeloproliferative neo..:

Ajufo, Helen O ; Waksal, Julian A ; Mascarenhas, John O.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410182/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Clinical Utility of Fedratinib in Myelofibrosis:

Waksal, Julian A ; Tremblay, Douglas ; Mascarenhas, John
info:eu-repo/semantics/altIdentifier/doi/10.2147/OTT.S267001.  , 2021
Link: https://www.dovepress.co..
 
?
14

Clinical Utility of Fedratinib in Myelofibrosis:

Waksal, Julian A ; Tremblay, Douglas ; Mascarenhas, John
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387309/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

Incorporation of Novel Therapies for the Treatment of Acute..:

Waksal, Julian A ; Tallman, Martin S
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631181/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15